|
Lymphoepithelioma-like carcinoma of the lung.Respirology.
2006 Sep;11(5):539-45.
Lymphoepithelioma-like
carcinoma (LELC) of the lung was first reported in 1987. In the past
two decades, there have been just more than 150 cases reported in the
literature. This uncommon but distinct form of non-small cell lung
carcinoma has a predilection for young non-smoking Asians, without
gender distinction. Histologically, it is indistinguishable from
undifferentiated nasopharyngeal carcinoma. The carcinogenic role of
latent Epstein-Barr virus infection in causing LELC of the lung has
been evident almost exclusively in Asians compared with Caucasians.
Among the reported cases, more than half were in early resectable
stages (I or II) and there was a tendency for peribronchovascular
spread with vascular encasement in advanced diseases. In order to
establish the diagnosis of LELC of the lung, both nasopharyngeal
carcinoma and lymphoma have to be excluded by endoscopic biopsy (with
or without magnetic resonance imaging of the nasopharynx) and
immunohistochemical staining of the biopsy samples. The mainstay of
treatment for early-stage disease is curative surgical resection,
whereas multimodality treatment (surgery, chemotherapy, radiotherapy)
has been adopted in advanced or metastatic diseases. The overall
survival is more favourable in LELC of the lung compared with non-LELC
type of non-small cell lung carcinoma. Future collaborative studies
especially on optimizing treatment for this uncommon malignancy are
clearly warranted.
Lymphoepithelioma-like carcinoma of the lung: radiologic features of
an uncommon primary pulmonary neoplasm.AJR
Am J Roentgenol. 2006 May;186(5):1294-9.
OBJECTIVE: The purpose of this study was to review the chest
radiographic, CT, and MRI appearances of primary pulmonary
lymphoepithelioma-like carcinoma (LELC). CONCLUSION: Primary pulmonary
LELC is histopathologically identical to nasopharyngeal carcinoma. The
radiographic, CT, and MRI features of primary pulmonary LELC are
nonspecific, often resembling those of bronchogenic carcinoma. Primary
pulmonary LELC usually presents as a poorly circumscribed, enhancing,
peripheral solitary pulmonary nodule on CT; necrosis may be present
and is considered a poor prognostic sign. MRI shows isointense to
low-intensity signal on T1-weighted images and mildly increased signal
on T2-weighted images; enhancement of abnormal tissue is typical. Most
patients present with early-stage disease. Primary pulmonary LELC
should be suspected in selected patients and requires differentiation
from bronchogenic carcinoma and metastatic nasopharyngeal carcinoma.
Lymphoepithelioma-like carcinoma of the lung: case in which the
patient has been followed up for 7 years postoperatively.Jpn
J Thorac Cardiovasc Surg. 2005
Dec;53(12):653-6.
Primary
lymphoepithelioma-like carcinoma (LELC) of the lung is a very rare
disease. There is very little long term follow-up data about this
disease. A 60-year-old woman was found to have abnormalities according
to a routine chest X-ray examination. She was admitted to our hospital
in March 1998. Since a malignant tumor of the right lung was
suspected, surgical resection was performed in April of the same year.
Pathological diagnosis was LELC of the lung. Its pathological stage
was T1N0M0 stage IA. It has been reported that this carcinoma is
associated with Epstein-Barr virus (EBV) infection. However, the
patient's tumor cells were negative for EBV as examined with RNA in
situ hybridization technique. She is alive and has been free from
recurrence of the disease over 7 years postoperatively.
Primary
lymphoepithelioma-like carcinoma of the lung.Tuberk
Toraks. 2005;53(1):69-73.
Lymphoepithelioma-like carcinoma (LELC), best known to occur in the
nasopharynx, can arise in a variety of sites, such as the salivary
gland, thymus, lung, stomach, and skin. Primary LELC of the lung is
very rare, with only limited information in the literature. We
presented a case of a 66-year-old white man with a T2N0M0
lymphoepithelioma-like carcinoma of the lung. Immunohistochemical
analysis was negative for Epstein-Barr virus. Observation of the
nasopharynx and a computerized tomography of the cavum were normal.
Computed
tomography characteristics of advanced primary pulmonary
lymphoepithelioma-like carcinoma.Eur
Radiol. 2003 Mar;13(3):522-6. Epub 2002
Jul 16.
Our objectives
were to document CT features of advanced primary pulmonary
lymphoepithelioma-like carcinoma (LELC) and to determine features that
may assist differentiation from other non-small cell lung cancers (NSCLC).
Imaging and clinical data of all patients with biopsy-proven pulmonary
LELC ( n=12) were retrieved from a database of all NSCLC patients over
a 2-year period. Twenty-five controls were recruited from other
inoperable non-LELC NSCLC patients from the database. Pre-treatment CT
scans of the thorax of both study and control patients were reviewed
for lobe involved; tumour site, borders and size; and pleural,
vascular or pulmonary involvement. Presence of lymphangitis
carcinomatosis was noted. Lymph node metastasis was characterised as
ipsilateral or contralateral enlarged (>1 cm) mediastinal or hilar
nodes, or as peribronchovascular nodal spread. Differences between the
two groups were tested using Mann-Whitney rank-sum test. The LELC
tumours were significantly larger (45.67 vs 17.71 cm(2)) than controls
and were closely associated with the mediastinum. There were more LELC
tumours with well-defined borders ( p<0.001) and fewer with spiculated
borders ( p<0001) than non-LELC tumours. There was increased
peribronchovascular nodal spread ( p=0.01) and vascular encasement (
p=0.02) in LELC compared with non-LELC tumours. Advanced primary
pulmonary LELC has distinct radiological features, and can appear as
well-defined tumour closely associated with the mediastinum, with
peribronchovascular spread and vascular encasement.
Clinicopathologic features
and prognosis of lymphoepithelioma-like carcinoma of the lung.Zhonghua
Bing Li Xue Za Zhi. 2001
Oct;30(5):328-31.
OBJECTIVE: To analyze the clinicopathologic features and prognosis of
lymphoepithelioma-like carcinoma (LELC) of the lung. METHODS: 26 cases
of pulmonary LELC with available long-term follow-up information were
compared with 84 cases of pulmonary non-LELC(33 cases of squamous cell
carcinoma, 36 cases of adenocarcinoma, 6 cases of adeno-squamous
carcinoma and 9 cases of large cell carcinoma) with available
long-term follow-up information using Kaplan-Meier method and the
generalized Wilcoxon test. RESULTS: LELC of the lung had a better
prognosis than non-LELC (P < 0.05). Further study showed that
pulmonary LELC had a significantly better prognosis than
adeno-squamous carcinoma and large cell carcinoma. However, there was
no significant prognostic differences between pulmonary LELC and
squamous cell carcinoma and adenocarcinoma. Tumor recurrence and
necrosis (> or = 5% of tumor) were associated with poor prognosis.
CONCLUSION: Pulmonary LELC, which is a very rare and unique entity,
has a better prognosis after therapy.
Lymphoepithelioma-like
carcinoma of the lung with a better prognosis. A clinicopathologic
study of 32 cases.Am
J Clin Pathol. 2001 Jun;115(6):841-50.
The purpose of
our study was to clarify the prognosis of lymphoepithelioma-like
carcinoma (LELC) of the lung, which is rare. We analyzed the
clinicopathologic features of 32 cases of pulmonary LELC and compared
the cases with 84 cases of pulmonary non-LELC with available long-term
follow-up information. The results show that LELC of the lung as a
distinct entity has a better prognosis than non-LELC. We found a
significant difference in the survival rates between patients with
LELC and patients with non-LELC in stage II and stages III and IV,
respectively. Tumor recurrence and necrosis (5% or more of tumor) are
associated with a poor prognosis. It seems that the histologic typing
(Regaud type and Schmincke type) of pulmonary LELC is of no clinical
value.
Primary
lymphoepithelioma-like carcinoma of the lung. A clinicopathologic
study of 11 cases.
Cancer. 1995 Aug 1;76(3):413-22.
BACKGROUND.
Lymphoepithelioma-like carcinoma (LELC), best known to occur in the
nasopharynx, can arise in a variety of sites, such as the salivary
gland, thymus, lung, stomach, and skin. Primary LELC of the lung is
very rare, with only limited information in the literature. METHODS.
The clinicopathologic features of 11 patients with pulmonary LELC
collected from two regional hospitals in Hong Kong are described.
RESULTS. The patients, all Chinese, were aged 38 to 73 years (median,
54 years), with equal sex incidence. Two of the 8 patients were
smokers. Four presented with coin lesions incidentally discovered on
chest X-ray, five with cough and blood-stained sputum, and two with
pleural effusion. The tumor formed a discrete (9 patients) or an
ill-defined (1 patient) nodule in the lung, or, rarely, showed
extensive bilateral pulmonary involvement (1 patient). The major
bronchi were not involved except in 1 patient. Three patients had
lymph node metastasis at presentation; two of them had bone
metastasis, one at presentation and one after 9 months. The tumors had
pushing margins, and grew in the form of anastomosing islands and
sheets, comprising syncytial-appearing large cells with vesicular
nuclei and prominent nucleoli. They were infiltrated by an appreciable
number of small lymphocytes and plasma cells. Intratumoral amyloid
globules were found in one tumor. In five patients, the tumor showed
intraepithelial growth within the small bronchi; this could represent
either the in-situ phase of the tumor or pagetoid spread into the
bronchial epithelium. The neoplastic cells of all patients harbored
Epstein-Barr virus (EBV) as demonstrated by in situ hybridization for
EBV-encoded small nuclear RNAs. All eight Asian patients with
pulmonary LELC previously reported in the literature similarly have
been EBV-positive, whereas the four reported Caucasian patients all
have been EBV-negative. CONCLUSION. Lymphoepithelioma-like carcinoma
of lung occurring in Asians is an EBV-associated neoplasm; it also
appears to occur at a higher frequency in Asians than Caucasians. It
usually presents as a solitary subpleural nodule, and there is no
strong association with cigarette smoking. Most patients have early
stage disease at presentation. From the limited available data, the
behavior of LELC of lung is highly variable, ranging from apparent
curability by excision (particularly for localized disease) to highly
aggressive, extensive disease at presentation.
|